NCT07389044
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Virus Infection, +15 more
- Locations
-
- Arensia Exploratory Medicine Chisinau Chisinau, Moldova
- New Zealand Clinical Research Auckland, New Zealand
Clinical trial condition
Chronic Hepatitis B Virus Infection
Explore clinical trials studying Chronic Hepatitis B Virus Infection. Study availability and eligibility vary by location and protocol.
7 public trials
2 recruiting studies
Chronic Hepatitis B Virus Infection trial results
NCT07519330
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Virus Infection, +15 more
- Locations
-
- Chongqing University Three Gorges Hospital Chongqing, Chongqing Municipality, China
NCT07515209
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Virus Infection, +15 more
- Locations
-
- NanFang Hospital of Southern Medical University Guangzhou, Guangdong, China
- The Affiliated Panyu Central Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
- The Eighth Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China
Completed
Efficacy and Safety Study of Peginterferon Alfacon-2 to Treat Chronic Hepatitis B Virus Infection
NCT06544551
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Virus Infection, +15 more
- Locations
-
- Beijing Ditan Hospital, Capital Medical University Beijing, China
- Beijing Youan Hospital, Capital Medical University Beijing, China
- Peking university Peoole's hospital Beijing, China
- The First Hospital of Jilin University Changchun, China
NCT01708889
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Virus Infection, +16 more
- Locations
-
- Clinical Pharmacology Of Miami Inc. Miami, Florida, United States
- Orlando Clinical Research Center Orlando, Florida, United States
- New Orleans Center For Clinical Research - Knoxville Knoxville, Tennessee, United States
Active, Not Recruiting
A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)
NCT06537414
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Virus Infection, +15 more
- Locations
-
- GSK Investigational Site San Francisco, California, United States
- GSK Investigational Site San Jose, California, United States
- GSK Investigational Site Minneapolis, Minnesota, United States
- GSK Investigational Site New York, United States
Active, Not Recruiting
Investigate the Efficacy and Safety of BRII-835 (VIR-2218) and PEG-IFNα Combination Therapy in Chronic HBV Patients
NCT05970289
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B Virus Infection, +15 more
- Locations
-
- Investigative Site 61001 Kingswood, New South Wales, Australia
- Investigative Site 61002 Birtinya, Queensland, Australia
- Investigative Site 61003 Melbourne, Victoria, Australia
- Investigative Site 86001 Beijing, Beijing Municipality, China